Eugene

[email protected]

LATEST

Celgene, bluebird bio Partner in CAR-T Therapies
By

By
Celgene Corporation and bluebird bio, a Cambridge, Massachusetts-based clinical-stage gene-therapy company, have agreed to co-develop and co-promote bb2121, an investigational anti-B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T cell…

Allied Patients Launches as Start-up Generics Company
By

By
Allied Patients, a US-based development and manufacturing network, has launched as a new company to develop affordable generic medications. Eduardo Matto, MD, a military physician, is chief executive officer and…

KBI Biopharma, ReForm Biologics Partner for Biopharm Formulations
By

By
KBI Biopharma, a Durham, North Carolina-headquartered biopharmaceutical contract development and manufacturing organization, has partnered with ReForm Biologics, a Cambridge, Massachusetts-headquartered formulation innovator for protein therapeutics, to make biopharmaceutical formulations. Through…

Emergent Announces Executive Management Changes
By

By
Emergent BioSolutions, a Gaithersburg, Maryland-headquartered specialty pharmaceutical company and contract manufacturer, has announced executive management changes. The company’s Board of Directors has promoted Robert G. Kramer Sr. to the newly-created…

Dr. Reddy’s Laboratories Announces Senior Leadership Changes
By

By
Dr. Reddy’s Laboratories, a Hyderabad, India-headquartered pharmaceutical company, has announced a change in the makeup of its senior leadership team. Following a 15-year career with the company, Abhijit Mukherjee, Chief…

Porton Biopharma Receives Grant from UK Gov’t for Clostridia-Based Drug Manufacturing
By

By
Porton Biopharma, a Salisbury, UK-headquartered biopharmaceutical company, has obtained grant funding from Innovate UK, the UK government’s innovation agency, to investigate the manufacture of a new class of medicines that…

FDA, EMA Accept Pfizer’s Filings for Lung Cancer Drug Dacomitinib
By

By
The US Food and Drug Administration (FDA) has accepted Pfizer’s new drug application and granted priority review for dacomitinib, a pan-human epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI),…

Daiichi Sankyo in Cancer Target Pact
By

By
Daiichi Sankyo Company and DarwinHealth, a New York-headquartered technology-focused cancer medicine company, have formed a research agreement providing Daiichi Sankyo with exclusive access to DarwinHealth’s proprietary cancer target database in…

AstraZeneca, Ionis in License Pact for Liver Disease Drug
By

By
AstraZeneca has licensed a drug (IONIS-AZ6-2.5-LRx) from Ionis Pharmaceuticals, a Carlsbad, California-based pharmaceutical company, for treating nonalcoholic steatohepatitis (NASH), a liver disease, following advancement of the drug into development. IONIS-AZ6-2.5-LRx…

Roche Completes $1.9-Billion Acquisition of Flatiron Health
By

By
Roche has completed its acquisition of Flatiron Health, a New York-headquartered healthcare technology and services company focused on oncology, for $1.9 billion. The companies announced the acquisition in February 2018.…